Fairfax, Bain look to buy Gujarat API company Farmson

Posted on:
Key Points

Canadian billionaire Prem Watsa's Fairfax Group and Bain Capital are vying for a buyout of Vadodara-based active pharmaceuticals ingredient (API) maker Farmson Basic Drugs in a deal valuing the company at 4,000 crore..

Farmson, founded in 1969 by KK Vithani, is among the largest makers of API paracetamol globally..

Farmson Basic Drugs (formerly Farmson Pharmaceutical Gujarat) is one of the leading paracetamol manufacturers in India and has the largest installed capacity for paracetamol manufacturing in the country..

Farmson supplies APIs to major pharmaceutical companies across India such as Sun Pharma, Alembic, Aurobindo, Cipla, Wockhardt, Intas, Ipca and global majors such as Gsk, J&J, Sanofi and Reckitt..

It has two manufacturing units in Vadodara for manufacturing paracetamol with aggregate capacity of 40,800 metric tonnes per annum (MTPA) and one unit for manufacturing para amino phenol (PAP)-key raw material for paracetamol, which is located at Jhagadia, Gujarat.. . Farmsons focuses solely on the manufacturing of paracetamol resulting in concentrated product profile, said a CARE Ratings report..